Hjem › Follikulært lymfom › California › Los Angeles
Kliniske studier for Follikulært lymfom i Los Angeles, CA
11 studier for Follikulært lymfom søker deltakere på steder i og rundt Los Angeles (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
RekruttererFrivillige helsepersonell ønskes velkommen
- Community Health Project Los Angeles (CHPLA), Los Angeles
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
NEO100 and High-Grade Meningioma
RekruttererFase 2
- University of Southern California, Los Angeles
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
RekruttererFase 3
- David Geffen School of Medicine at UCLA, Los Angeles
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RekruttererFase 3
- University of California, Los Angeles, Los Angeles
A Study of ARC-02 in B-cell NHL
RekruttererFase 1
- Start Cala, Los Angeles
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
RekruttererFase 3
- David Geffen School of Medicine at UCLA, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
RekruttererFase 1
- START Los Angele, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekruttererFase 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Follikulært lymfom-studier i andre byer
- New York City, NY24 studier
- Milwaukee, WI19 studier
- Nashville, TN18 studier
- Houston, TX18 studier
- Boston, MA17 studier
- Baldwin Park, CA16 studier
- Seattle, WA15 studier
- Durham, NC15 studier
- Salt Lake City, UT13 studier
- Columbus, OH13 studier
- Chicago, IL12 studier
- San Antonio, TX12 studier
Andre studier i Los Angeles
- Ikke-småcellet lungekreft87 studier
- Kreft (alle typer)74 studier
- Brystkreft73 studier
- Prostatakreft61 studier
- Kolorektal kreft59 studier
- Metastatisk kreft57 studier
- Eggstokkreft50 studier
- Lungekreft45 studier
- Plateepitelcancer i hode og hals42 studier
- Pankreaskreft35 studier
- Endometriekreft34 studier
- Melanom34 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.